VIR BIOTECHNOLOGY INC (VIR) Stock Balance Sheet
NASDAQ:VIR • US92764N1028
Current stock price
8.4 USD
-0.56 (-6.25%)
At close:
8.4988 USD
+0.1 (+1.18%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 232.19M | 222.95M | 241.58M | 848.60M | 347.80M | |||
| Marketable Securities | 234.83M | 682.40M | 1.28B | 1.55B | 360.30M | |||
| Receivables | N/A | N/A | N/A | 0.00 | 773.10M | |||
| Other Current Assets | 47.06M | 137.11M | 65.82M | 117.10M | 81.60M | |||
| Total Current Assets | 514.08M | 1.04B | 1.59B | 2.52B | 1.56B | |||
| Non-Current Assets | ||||||||
| PPE Net | 117.72M | 122.86M | 167.20M | 188.20M | 130.10M | |||
| Investments And Advances | 314.57M | 190.01M | 105.28M | 23.90M | 201.40M | |||
| Goodwill | 16.94M | 16.94M | 16.94M | 16.90M | 16.90M | |||
| Intangibles | 7.85M | 8.12M | 22.57M | 32.80M | 33.30M | |||
| Other Non-Current Assets | 31.66M | 18.42M | 18.86M | 21.20M | 9.80M | |||
| Total Non-Current Assets | 488.74M | 356.35M | 330.83M | 283.00M | 391.50M | |||
| TOTAL ASSETS | 1.00B | 1.40B | 1.92B | 2.80B | 1.95B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 83.01M | 85.87M | 104.22M | 489.10M | 141.50M | |||
| Accounts Payable | 9.80M | 5.08M | 6.33M | 6.40M | 6.50M | |||
| Other Current Liabilities | 0.00 | 28.71M | 64.85M | 15.50M | 193.20M | |||
| Total Current Liabilities | 92.81M | 119.66M | 175.41M | 511.00M | 341.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 3.30M | 18.40M | |||
| Other Non-Current Liabilities | 144.73M | 128.77M | 153.42M | 209.80M | 162.70M | |||
| Total Non-Current Liabilities | 144.73M | 128.77M | 153.42M | 213.10M | 181.20M | |||
| TOTAL LIABILITIES | 237.55M | 248.43M | 328.82M | 724.10M | 522.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.20B | -759.78M | -237.82M | 377.20M | -138.60M | |||
| Additional Paid In Capital | 1.97B | 1.91B | 1.83B | 1.71B | 1.57B | |||
| Common Shares | 14.00K | 14.00K | 13.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 139.47M | 136.96M | 134.78M | 133.20M | 131.20M | |||
| Tangible Book Value per Share | 5.31 | 8.22 | 11.51 | 15.23 | 10.53 | |||
| Total Shareholders' Equity | 765.28M | 1.15B | 1.59B | 2.08B | 1.43B | |||
| TOTAL LIABILITIES AND EQUITY | 1.00B | 1.40B | 1.92B | 2.80B | 1.95B | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 5.54 | 8.71 | 9.05 | 4.93 | 4.58 | |||
| Return On Assets (ROA) | -43.68% | -37.31% | -32.05% | 18.41% | 27.05% | |||
| Return On Equity (ROE) | -57.23% | -45.37% | -38.68% | 24.82% | 36.92% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 28.73% | 20.61% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 36.73% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | 38.89% | |||
All data in USD , ROIC based on taxRate of 0.21